Variable | β | Standard Error | Chi-Square | P | HR(95% CI) |
---|---|---|---|---|---|
Age group | −0.72 | 0.43 | 2.83 | 0.0923 | 0.49(0.21 ~ 1.13) |
Menopause | 0.76 | 0.44 | 3.00 | 0.0835 | 2.14(0.9 ~ 5.06) |
Stage (early or late) | 1.48 | 0.39 | 14.63 | 0.0001* | 4.40(2.06 ~ 9.4) |
Histotype | −0.36 | 0.28 | 1.69 | 0.1941 | 0.7(0.4 ~ 1.2) |
Lymph node positive | 0.11 | 0.38 | 0.09 | 0.7667 | 1.12(0.53 ~ 2.36) |
Lymphadenectomy | 0.43 | 0.33 | 1.73 | 0.1887 | 1.54(0.81 ~ 2.95) |
Residual disease | 0.51 | 0.28 | 3.47 | 0.0625 | 1.67(0.97 ~ 2.87) |
CA125 normal | 0.68 | 0.56 | 1.51 | 0.219 | 1.98(0.67 ~ 5.89) |
Tumor side | 0.29 | 0.27 | 1.17 | 0.2797 | 1.34(0.79 ~ 2.28) |
Endometriosis | −0.39 | 0.47 | 0.70 | 0.4038 | 0.68(0.27 ~ 1.69) |
Chemotherapy course | −0.78 | 0.28 | 7.61 | 0.0058* | 0.46(0.26 ~ 0.8) |
Chemoresistance | 1.94 | 0.32 | 37.68 | <.0001* | 6.96(3.75 ~ 12.93) |
Hypertension | 0.77 | 0.30 | 6.61 | 0.0102* | 2.16(1.2 ~ 3.89) |